“The NSF/ANSI 455 GMP mark indicates that an NSF International auditor has audited a facility, checked documents, and deemed the facility compliant with GMP regulations for production,” said David Trosin, Managing Director, Global Health Sciences Certification at NSF International. “We’re very pleased to grant NSF/ANSI 455 GMP certification to the ECS Nutraceuticals Group manufacturing facility.”
The NSF/ANSI 455 GMP standards combine regulatory requirements with retailer quality requirements, in order to help strengthen safety and quality of the products and trust in the supply chain.
Related: Whole Foods Market Launches Program in Support of Responsible Sourcing Harvard/NSF Study Tests for Harmful Stimulants in Sports Nutrition; CRN Weighs In 2021 Phytocannabinoids Market Update: Troubleshooting & Trendspotting
“As an experienced company that has been committed to following good manufacturing practices from the start, obtaining the NSF GMP registration demonstrates ECS Nutraceuticals’ commitment to set a new standard of trust in the hemp product market,” said ECS President, Gerard McIntee, in the press release. “Beyond providing thorough independent testing to confirm our finished product quality, this registration provides further assurance for health professionals that they are supplying their patients with safe CBD products that meet stringent quality standards throughout every step of the manufacturing process.”
